“Lymphoma red flag”的搜索结果，显示 41-50 项，共有 9068 项

1. 血液科- 临床试验- 妙佑医疗国际

   A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this trial is to ...

2. Mayo Clinic Cancer Physician Update - July 2024

   Page 1.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

4. Mayo Clinic Cancer Physician Update - March 2025

   Page 1.

5. 霍奇金淋巴瘤（霍奇金病） - 症状与病因- 妙佑医疗国际

   Schedule your lymphoma appointment ... We are accepting new patients. Our team of experts is standing by to schedule your Hodgkin's lymphoma appointment now. Call ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss. Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study ...

7. 血液科- 临床试验- 妙佑医疗国际

   A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this trial is to ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

9. 血液科- 临床试验- 妙佑医疗国际

   ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

10. 血液科- 临床试验- 妙佑医疗国际

    ... lymphoma who have achieved a complete response after initial chemotherapy. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma.